Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy

• Váldodahkkit: Zhang C (Dahkki), Duan S (Dahkki), Guo M (Dahkki), Yuan Y (Dahkki), Huang Z (Dahkki), Zhu J (Dahkki), Sun B (Dahkki), Zhang B (Dahkki), Xing C (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Dove Medical Press, 2020-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Chengning Zhang,1,* Suyan Duan,1,* Miao Guo,2 Yanggang Yuan,1 Zhimin Huang,1 Jingfeng Zhu,1 Bin Sun,1 Bo Zhang,1 Changying Xing1 1Departments of Nephrology; 2Department of Pharmacy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, People’s Republic of C...